GLP-1 diabetes and weight-loss drug side effects: "Ozempic face" and more Reviewed by Howard E
527 Conclusions and perspective Primarily recognized for their role in diabetes mellitus treatment, GLP-1RAs have demonstrated significant benefits in cardiovascular health, skeletal muscle-related diseases, obesity management, and neurodegenerative conditions, among others
This approach offers a practical way for facility designers to align corporate sustainability goals with overall operational resilience
Analysis of FAERS data from 2003 to 2024 showed significant associations between diabetic retinopathy and semaglutide (PRR, 19.43), dulaglutide (PRR, 9.01), and liraglutide (PRR, 4.4) [95]
Available from: What making weight-loss drugs means for the environment [Online]
Others express concerns about long-term use, side effects, cost, and the importance of building sustainable nutrition and exercise habits